( Editors Note: The Wisconsin Technolo...)Angel Investing in Wisconsin
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Angel Investing in Wisconsin
Editors Note: The Wisconsin Technology Network has received an exclusive advance copy of NorthStar Economics 60-page report titled, the NorthStar Guide to Growth and Venture Capital in Wisconsin. This report contains a primer for Wisconsin companies seeking information about risk capital available in the sta......
Full article >>>
'"/>
Source:wistechnology.com By Dr. David J. Ward. PhD and Jim Patterson, NorthStar Economics 11/02/03
Related biology technology :
1. TrafficCast secures $2M from Phenomenelle Angels, NEW Capital Fund
2. Angel investors commit $12.7B in first half of `06
3. Angel network introduces ePlan
4. Angel fund to focus on women and minority businesses
5. Angel investing should lead to more venture funding, Ward says
6. Angel investing should lead to more venture funding, Ward says
7. Midwest fares surprisingly well at Venture Forum in Los Angeles
8. Bone Care bought for $600 million; Wisconsin Angel Network launches
9. Wisconsin Angel Network is part of states focus on entrepreneurship
10. Angel groups in Chicagoland beginning to sprout
11. Angel investor boot camp advises and educates cherubs
Post Your Comments:
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2
[0] Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia[0] Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans[0] Marrone Bio Innovations Announces Two New Executive Appointments[0] Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer
Other Biology Technology:PNAS paper and its authors honored for scientific excellence 2Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference 2ThermoGenesis Corp. Announces Voluntary Recall of Selected Lots of AXP Bag Sets 2
Breaking Biology News(10 mins):Roe of marine animals is best natural source of omega-3 2Kornberg Associates | Architects Completes UC Riverside Stem Cell Core Facility Project 2New science estimates carbon storage potential of US lands 2State Regulation of Massage Therapy Will Improve Public Health Safety 53783 1State Regulation of Massage Therapy Will Improve Public Health Safety 53783 2State Regulation of Massage Therapy Will Improve Public Health Safety 53783 3Memorial Blood Centers Joins Extreme Makeover 3A Home Edition As Designated Charity 53779 1Memorial Blood Centers Joins Extreme Makeover 3A Home Edition As Designated Charity 53779 2Memorial Blood Centers Joins Extreme Makeover 3A Home Edition As Designated Charity 53779 3Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 1Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 2Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 3Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 4Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 5Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 6
Other Biology News:BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet 2PTC124 shows activity in cystic fibrosis; Phase 2 proof-of-concept data published in Lancet 3New 'nano-positioners' may have atomic-scale precision 2New 'nano-positioners' may have atomic-scale precision 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |